Study: Hydrogel shows promise in preventing transplant rejection

08/14/2014 | American City Business Journals

U.S. scientists have created an easy-to-produce and low-cost hydrogel that they say could help prevent rejection of limb, hand or face transplants by allowing more targeted and slower delivery of immunosuppressant drugs. A study in the journal Science Translational Medicine found that rats with hind-leg transplants experienced no graft rejection for more than 100 days after receiving the hydrogel filled with the immunosuppressive drug tacrolimus.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA